Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET/CT

American Journal of Roentgenology

Volumn 193, Issue 6, 2009, Pages 1640-1645

  Werner, Matthias K ^a,b   Parker, J Anthony ^a   Kolodny, Gerald M ^a   English, Jeffrey R ^a   Palmer, Matthew R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

FDG PET CT; Lesion size; Lung cancer; Pulmonary nodules; Respiratory gating; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HUMAN; LUNG LESION; LUNG NODULE; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RESPIRATORY-GATED IMAGING TECHNIQUES; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73449114294     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.2516     Document Type: Article

References (25)

1. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and wholebody MRI for tumor staging in oncology. JAMA 2003; 290:3199-3206
2. Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med 2000; 41:661-681
3. Allen-Auerbach M, Yeom K, Park J, Phelps M, Czernin J. Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. J Nucl Med 2006; 47: 298-301
4. Erdi YE, Nehmeh SA, Pan T, et al. The CT motion quantitation of lung lesions and its impact on PETmeasured SUVs. J Nucl Med 2004; 45:1287-1292
5. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 2006; 47:1808-1812
6. Kawano T, Ohtake E, Inoue T. Deep-inspiration breath-hold PET/CT of lung cancer: maximum standardized uptake value analysis of 108 patients. J Nucl Med 2008; 49:1223-1231
7. Dahlbom M. Estimation of image noise in PET using the bootstrap method. IEEE Trans Nucl Sci 2002; 49:2062-2066
8. Nehmeh SA, Erdi YE, Ling CC, et al. Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer. Med Phys 2002; 29:366-371
9. Nehmeh SA, Erdi YE, Pan T, et al. Quantitation of respiratory motion during 4D-PET/CT acquisition. Med Phys 2004; 31:1333-1338
10. Nehmeh SA, Erdi YE, Pan T, et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 2004; 31:3179-3186
11. Goerres GW, Burger C, Kamel E, et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003; 226: 906-910
12. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 2007; 48:932-945
13. Erdi YE, Mawlawi O, Larson SM, et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 1997; 80:2505-2509
14. Jeong YJ, Yi CA, Lee KS. Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. AJR 2007; 188:57-68
15. Silvestri GA, Gould MK, Margolis ML, et al.; American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132[suppl 3]:178S-201S
16. Korreman SS, Juhler-Nottrup T, Fredberg PG, et al. The role of image guidance in respiratory gated radiotherapy. Acta Oncol 2008; 47:1390-1396
17. Bradley JD, Perez CA, Dehdashti F, Siegel BA. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med 2004; 45[suppl 1]:96S-101S
18. 18F]fluoro- D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer. Mol Imaging Biol 2002; 4:257-263
19. 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005; 46:1342-1348
20. 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007; 34:453-462
21. Guckenberger M, Krieger T, Richter A, et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 2009; 91:288-295
22. 18F-FDG PET/CT. J Nucl Med 2007; 48:744-751
23. Spaepen K, Stroobants S, Dupont P, et al. [(18)F] FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction? Eur J Nucl Med Mol Imaging 2003; 30:682-688
24. Cai W, Chen K, He L, Cao Q, Koong A, Chen X. Quantitative PET of EGFR expression in xenograft-bearing mice using (64)Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. Eur J Nucl Med Mol Imaging 2007; 34:850-858
25. 18F]FEAU. Nat Protoc 2007; 2:416-423